Original ResearchPublished 6 October 2026Association of statin use with reduced risk of Alzheimer’s disease: findings in UK BiobankHui Yang · Can Zhu · Jialu He · Yan Wei · Dongmei Li · Xuan Luo · Ying WangFrontiers in Aging Neurosciencedoi 10.3389/fnagi.2026.1961033
ReviewPublished 1 July 2026Cardiovascular risk in systemic lupus erythematosus: beyond Framingham to emerging risk prediction tools and therapeutic approachesMona Aflaki · Joanne M. BargmanFrontiers in Lupusdoi 10.3389/flupu.2026.1725054
Brief Research ReportPublished 27 April 2026Increasing CD4/CD8 ratio confirmed after two years of long-acting cabotegravir and rilpivirine in the SCohoLART studyGabriele Loi · Nicolò Capra · Riccardo Lolatto · Marcella Negri · Gaia Catalano · Flavia Passini · Nicolò Moschetta · Claudia Benelli · Silvia Nozza · Antonella Castagna · Camilla MucciniFrontiers in Virologydoi 10.3389/fviro.2026.1819287
ReviewPublished 31 March 2026Revisiting old drugs and drug combinations for polycythemia vera and related neoplasmsGökhan Mergen · Hans C. HasselbalchFrontiers in Hematologydoi 10.3389/frhem.2026.1749376
Mini ReviewPublished 4 February 2026The urgent need for randomized controlled trials in pregnant women with antiphospholipid antibodies—protecting women through researchChristine Graversgaard Adams · Jullie Rudnicki · Berit Fabricius Petersen · Søren Jacobsen · Karen SchreiberFrontiers in Lupusdoi 10.3389/flupu.2026.1747204
